Pharmaceuticals News and Research

RSS

Pharmaceutical Benefits Scheme (PBS) medicines available faster

The time taken for medicines to list on the Pharmaceutical Benefits Scheme (PBS) will be significantly reduced under recommendations outlined in the report Working together to improve the Pharmaceutical Benefits Scheme - Review of the Post PBAC Processes Report released today.

27 Jul 2004

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Merck/Schering-Plough Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved VYTORIN™ (ezetimibe/simvastatin) for the treatment of high LDL cholesterol (LDL-C) in patients with primary hypercholesterolemia or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

26 Jul 2004

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Y's Therapeutics, a privately held biopharmaceutical company, said today it has submitted applications to the Ethics Committee and Ministry of Health (BfArM) in Germany to begin Phase II clinical trials for its two most advanced projects, YSIL6 for rheumatoid arthritis and YSTH2 for asthma.

26 Jul 2004

Emerging nanomedicine technologies could dramatically transform medical science

Emerging nanomedicine technologies could dramatically transform medical science as we know it today with their potential to address unmet medical needs and provide targeted therapy.

23 Jul 2004

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

The European Union has awarded €12 million to a network of scientists in 11 European countries and South Africa and the aim is to use plants to produce vaccines and treatments against major diseases including AIDS, rabies, diabetes and TB.

23 Jul 2004

One of the world’s most sophisticated systems for keeping electronic health records

The system, called VistA-Office Electronic Health Record, was developed by VA. A version of VistA is used at more than 1,300 VA facilities throughout the United States to maintain records on 5 million veterans who receive their health care from VA.

23 Jul 2004

AstraZeneca files for patent infringement

AstraZeneca has confirmed that it has filed a lawsuit in the U.S. District Court for the District of Delaware against the generic company Andrx for patent infringement.

23 Jul 2004

Plan B has been shown to reduce the risk of pregnancy by 89 percent

Barr Pharmaceuticals has announced that its subsidiary, Duramed Pharmaceuticals has submitted a formal response in support of its Supplemental New Drug Application (sNDA) for an Over-the-Counter (OTC) Plan B(R) emergency contraceptive product.

23 Jul 2004

New cream treatment for common form of skin cancer

The US Food and Drug Administration has approved a new treatment for some people with a very common form of skin cancer. Imiquimod cream, sold as Aldara, can now be used to treat superficial basal cell carcinoma.

23 Jul 2004

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Elan Corporation and Wyeth Pharmaceuticals have announced several key findings from their Phase IIa clinical trial of an investigational Alzheimer's disease (AD) treatment, AN-1792, which were presented in Philadelphia at the 9th International Conference on Alzheimer's Disease and Related Disorders.

22 Jul 2004

Natural organohalogens have potent anticancer and antibacterial activity

Human made chemical compounds called organohalogens get loads of attention as they are best known for their often harmful effect on the environment - substances like the CFCs (the ozone-damaging chemicals), dioxin (found in the herbicide Agent Orange), PCBs (industrial fluids) and several pesticides.

22 Jul 2004

Clinical study compares treatments in early Parkinson's disease

University of Tennessee Health Science Center professor and vice chair of the Department of Neurology, Ronald F. Pfeiffer, M.D., has been an investigator with The Parkinson Study Group (PSG), which recently reported four-year results of a major long-term, multi-center clinical trial.

21 Jul 2004

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Medicare could eliminate the coverage gap in its prescription drug benefit if it paid pharmaceutical prices comparable to those paid by citizens of Canada, the United Kingdom and France, according to a report by researchers from the Johns Hopkins Bloomberg School of Public Health and Pennsylvania State University

21 Jul 2004

Court ruling favors State over pharmaceutical manufacturers

Nevada Attorney General Brian Sandoval yesterday announced that Washoe County District Court Judge Steven R. Kosach has issued an important ruling in Nevada's Average Wholesale Price (AWP) litigation against numerous pharmaceutical manufacturers including Abbott Labs, Baxter, Bristol-Myers Squibb, Dey, GlaxoSmithKline, and Pharmacia.

21 Jul 2004

Neuro3d identifies candidate compound

The identification of this compound and extension of the research collaboration by J&JPRD further highlights the strength of Neuro3d's internal drug discovery capabilities.

21 Jul 2004

3M and MicroDose Technologies Inc. team up to bring advanced electronic dry powder inhaler to market

3M and MicroDose Technologies Inc., a privately held drug delivery company based in Monmouth Junction, N.J., announced today that the two companies have entered into an exclusive co-development and joint marketing agreement.

20 Jul 2004

Florida Attorney General issues civil subpoenas to six pharmaceutical manufacturers

Florida Attorney General Charlie Crist has issued civil subpoenas to six pharmaceutical manufacturers regarding their wholesale pricing practices.

20 Jul 2004

New book focuses on pharmaceutical care

Established pharmacists as well as those studying to gain their qualifications will benefit from a new book which focuses on pharmaceutical care in New Zealand.

19 Jul 2004

Market research 'World RNAi Markets: Current and Future Outlook'

Gene silencing by RNAi has now been identified as a crucial technology for target validation and therapeutics. By targeting and interfering with messenger RNA (mRNA), RNAi technology blocks the expression of the proteins implicated in disease progression.

19 Jul 2004

Obesity is not a 'disease' if it can be cured by taking regular walks and eating less

Hysteria over obesity - largely driven by an industry looking for a massive payday - has led the U.S. Department of Health and Human Services to open the door for Medicare to treat obesity as if it were a disease.

17 Jul 2004

Pharmaceuticals News and Research

Pharmaceutical Benefits Scheme (PBS) medicines available faster

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Y's Therapeutics files for clinical trials in Europe for rheumatoid arthritis and asthma

Emerging nanomedicine technologies could dramatically transform medical science

European scientists expect to begin human trials using pharmaceuticals grown in GM plants

One of the world’s most sophisticated systems for keeping electronic health records

AstraZeneca files for patent infringement

Plan B has been shown to reduce the risk of pregnancy by 89 percent

New cream treatment for common form of skin cancer

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Natural organohalogens have potent anticancer and antibacterial activity

Clinical study compares treatments in early Parkinson's disease

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Court ruling favors State over pharmaceutical manufacturers

Neuro3d identifies candidate compound

3M and MicroDose Technologies Inc. team up to bring advanced electronic dry powder inhaler to market

Florida Attorney General issues civil subpoenas to six pharmaceutical manufacturers

New book focuses on pharmaceutical care

Market research 'World RNAi Markets: Current and Future Outlook'

Obesity is not a 'disease' if it can be cured by taking regular walks and eating less

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News